TGF-β singaling and cancer: structural and functional consequences of mutations in Smads
Akiko Hata, Joan Massagué, Yigong Shi · Molecular Medicine Today · 1998
Cited by 161 works. doi:10.1016/s1357-4310(98)01247-7
Authors
References
- TGF-β SIGNAL TRANSDUCTION
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
- DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
- TGF-β signalling from cell membrane to nucleus through SMAD proteins
- The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.
- Bone morphogenetic proteins: multifunctional regulators of vertebrate development.
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
- Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster.
- MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma
- Receptor-associated Mad homologues synergize as effectors of the TGF-β response